Navigation Links
Hidden Heart Risk Revealed: Non-Profit Empowers 30% Of Americans At Risk To Be Advocates
Date:11/16/2013

SAN FRANCISCO, Nov. 16, 2013 /PRNewswire/ -- Cardiovascular disease is the #1 killer of Americans, yet 50% of hospital admissions for coronary artery disease have normal LDL-cholesterol.(i) The Lipoprotein(a) Foundation is revealing this hidden risk for patients.

"Patients with elevated Lipoprotein(a) [Lp(a)] levels have an increased risk of cardiovascular disease, including heart attack, stroke and peripheral arterial disease(ii). Lp(a) is a genetically-determined condition that is not responsive to lifestyle changes. Elevated Lp(a) levels are present in about 30% of the population at large(iii). Since Lp(a) is not currently routinely measured by physicians, many patients are unaware that they have elevated levels. Lp(a) can be measured with a routine lipid blood panel, but there is no adequate treatment currently to lower levels. Knowledge of elevated Lp(a) levels may motivate physicians to treat their patients' risk factors more aggressively and patients to live a heart healthy lifestyle until specific therapies can be developed and tested clinically," said Sotirios Tsimikas, M.D., Professor of Medicine and Director of Vascular Medicine at the University of California San Diego. "The Lipoprotein(a) Foundation is a needed resource for education of patients and their families that aims to raise public awareness of the potential risk of elevated Lp(a) levels that will hopefully lead to prevention and early treatment of cardiovascular disease."

"It is now documented that elevated Lp(a) levels not only cause heart attacks, but also aortic valve stenosis, another serious and potentially deadly heart disease. Therefore like those with heart attacks, individuals with aortic valve stenosis and their family members should have Lp(a) measured," said Professor, Chief Physician Børge Nordestgaard from Copenhagen University Hospital in Denmark. He adds "It is a great commitment to initiate the Lipoprotein(a) Foundation, as this may help more individuals and patients being diagnosed with this genetic disorder."(iv)

See Sandra's story here: http://youtu.be/1D3ahEbiLr4. Find out more about the mission of the Lipoprotein(a) Foundation and people can receive the latest information on Lp(a) by becoming members of the Lipoprotein(a) Foundation at www.lipoproteinafoundation.org.

Media Contact:
Sandra Tremulis
President and Founder 
serevill@aol.com
(650) 995-3242
http://www.lipoproteinafoundation.org

i Sachdeva A, Cannon CP, Deedwania PC, et al. Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines. AM Heart J 2009;157:111-7.e2.
http://www.ncbi.nlm.nih.gov/pubmed/19081406

ii Nordestgaard B, Chapman J, et al. Lipoprotein(a) as a cardiovascular risk factor current status. European Heart J 2010;31, 2844-2853
http://www.ncbi.nlm.nih.gov/pubmed/20965889

iii Tsimikas S, Hall J. Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease. J Am Coll Cardiol. 2012 Aug 21;60(8):716-21. doi: 10.1016/j.jacc.2012.04.038
http://www.ncbi.nlm.nih.gov/pubmed/22898069

iv Thanassoulis G, et al. Genetic associations with valvular calcification and aortic stenosis.N Engl J Med. 2013 Feb 7;368(6):503-12. doi: 10.1056/NEJMoa1109034
http://www.ncbi.nlm.nih.gov/pubmed/23388002


'/>"/>
SOURCE The Lipoprotein(a) Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Hidden Complications of Single-Sided Deafness
2. Consumers Are Advised to Be Aware of Hidden Costs in Some Discount Dental Plans
3. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
4. ChanRx to Present Results of Phase IIb Study in Atrial Fibrillation at the 2013 American Heart Association Scientific Sessions
5. 1,200th Worldwide Implant of the SynCardia Total Artificial Heart Occurs in Indiana
6. HeartWare Presentation At The Canaccord Genuity Medical Technology & Diagnostics Forum To Be Webcast
7. Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign
8. Millennium HealthCare Launches its Nation Wide Roll Out with Heart Smart Inc.
9. HeartWare International Reports $54.8 Million In Third Quarter 2013 Revenue; 140% Increase From Third Quarter Of 2012
10. Preventing Heart Disease One Step at a Time
11. Study Finds Pre-Hospital Administration Of Bivalirudin Substantially Improves Outcomes Compared To Heparin In Heart Attack Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... -- Non-invasive diagnostic test realizes the potential ... to be presented at Yissum’s booth, at IATI-BIOMED 2016 ... of the Hebrew University of Jerusalem announced today ... Ventures MKI, the technology investment arm of Morris Kahn ... for early detection of multiple diseases by analyzing circulating ...
(Date:5/22/2016)... May 23, 2016 DS ... anti-fibrotic and anti-inflammatory compound DS102 in chronic obstructive ... non-alcoholic steatohepatitis (NASH) patients. Recent DS ... in lung tissue and has bronchodilatory, anti-inflammatory and ... administration. The Company will publish further detail on ...
(Date:5/20/2016)... , May 20, 2016 ... Pipeline Review, H1 2016" market research report with ... Psoriasis (Psoriasis Vulgaris), complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... American Spine in ... invasive, endoscopic spine surgeries in the Montgomery County, Howard County and Washington, D.C. ... Germantown office of American Spine every Monday. He will also perform surgeries in ...
(Date:5/24/2016)... ... 24, 2016 , ... PhishLine, the best-in-class, enterprise level security ... Vice President of Sales. Cifolelli’s primary responsibilities include management of the company’s ... expanding field of organizational social engineering. , “We are delighted to have ...
(Date:5/24/2016)... ... 24, 2016 , ... i2i, a national leader in population ... “Transforming Outcomes” User Conference in Las Vegas on May 19-20, 2016. The ... the market standard for meaningful population health management. The company recently closed ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... and to housing, with more advantaged communities providing richer opportunities. Recognizing the key ... interventions: (a) school improvement policies; (b) school choice policies; (c) school desegregation policies; ...
(Date:5/24/2016)... ... May 24, 2016 , ... Mental health watchdog Citizens ... of Scientology and renowned professor of psychiatry Thomas Szasz, is continuing its protest against ... Industry of Death” exhibit in Atlanta, Georgia. The opening of the exhibit follows CCHR’s ...
Breaking Medicine News(10 mins):